Key Insights

Highlights

Success Rate

92% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 17/100

Termination Rate

6.7%

1 terminated out of 15 trials

Success Rate

91.7%

+5.2% vs benchmark

Late-Stage Pipeline

53%

8 trials in Phase 3/4

Results Transparency

45%

5 of 11 completed with results

Key Signals

5 with results92% success

Data Visualizations

Phase Distribution

14Total
Not Applicable (2)
P 1 (1)
P 2 (3)
P 3 (6)
P 4 (2)

Trial Status

Completed11
Recruiting2
Terminated1
Unknown1

Trial Success Rate

91.7%

Benchmark: 86.5%

Based on 11 completed trials

Clinical Trials (15)

Showing 15 of 15 trials
NCT07409103Phase 2RecruitingPrimary

A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)

NCT06456489Phase 3RecruitingPrimary

Pulse Steroid Injection in Refractory Rheumatoid Arthritis

NCT00393471Phase 3CompletedPrimary

Study Comparing Etanercept Plus Methotrexate to Either Etanercept or Methotrexate Alone in Rheumatoid Arthritis.

NCT02534896Phase 3TerminatedPrimary

To Evaluate The Efficacy And Safety Of Sunpharma1505 Compared With Reference1505 In Subjects With Active Rheumatoid Arthritis

NCT03172325Phase 3CompletedPrimary

Study to Demonstrate Non-Inferior Efficacy and Safety of CinnoRA® Versus Humira® for Treatment of Active RA

NCT04472481Phase 4CompletedPrimary

Vitamin D Effect in Rheumatoid Arthritis.

NCT03599986CompletedPrimary

Clinical Efficacy and Safety of Leflunomide in Egyptian Patients With Active Rheumatoid Arthritis

NCT03346590Not ApplicableUnknownPrimary

Evolution of Total Energy Expenditure and Its Various Components in Active Rheumatoid Arthritis (RA)Treated With Anti-TNF Agents and Comparison With Healthy Subjects

NCT01961505Not ApplicableCompletedPrimary

Topical Compound Tripterygium Wilfordii Hook F for Patients With Active Rheumatoid Arthritis

NCT02586246Phase 3CompletedPrimary

Long-term Treatment Study of CDP870 Self-injection in Patients With Active Rheumatoid Arthritis Who Are Participating in the Long-term Treatment Studies (Study 275-08-002 or Study 275-08-004) of CDP870

NCT00913458Phase 4CompletedPrimary

Study Evaluating Etanercept Plus Methotrexate in Early Rheumatoid Arthritis

NCT01008852Phase 2CompletedPrimary

Study Evaluating The Efficacy And Safety Of SBI-087 In Seropositive Subjects With Active Rheumatoid Arthritis

NCT00959036Phase 1CompletedPrimary

Study Evaluating Multiple Doses Of ATN-103 In Subjects With Active Rheumatoid Arthritis

NCT00420199Phase 3CompletedPrimary

A Phase IIIb Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate

NCT00882024Phase 2CompletedPrimary

Safety and Efficacy Study of Tranilast in Patients With Active Rheumatoid Arthritis (RA)

Showing all 15 trials

Research Network

Activity Timeline